Fabagal

agalsidase beta · ISU Abxis Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fabagal, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease [Phase 3]